SRNE Sorrento Therapeutics, Inc.
$0.00
Sorrento Therapeutics, Inc. (SRNE) is expected to report earnings on August 25, 2026, after the market close.
Earnings Date
Aug 25
Tuesday · After Close
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
-
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Sorrento Therapeutics, Inc.
Sorrento Therapeutics Inc is a biopharmaceutical company. It is engaged in the discovery, acquisition, development and commercialization of proprietary drug therapeutics for addressing unmet medical needs in the United States.
Sector
Healthcare